Archive for the ‘Vaccine’ Category
Emergent BioSolutions Receives NIAID Grant to Support Tuberculosis Vaccine Candidate
Posted by: fuadelhibri on March 29, 2012
Emergent BioSolutions Reports Financial Results for Full Year 2010
Posted by: fuadelhibri on April 13, 2011
Emergent BioSolutions Awarded HHS Contract Valued at up to $186.6 Million to Develop rPA Anthrax Vaccine
Posted by: fuadelhibri on September 20, 2010
Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Third Generation Anthrax Vaccine
Posted by: fuadelhibri on September 10, 2010
Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax
Posted by: fuadelhibri on July 15, 2010
Bad News Clouds Two Bio Defense Stocks
Posted by: fuadelhibri on December 10, 2009
Washington Launched Me, But I am Proud to be a Lebanese Dreaming of New Technology – Al Anwar
Posted by: fuadelhibri on October 15, 2009
Emergent BioSolutions Inc. (EBS) CEO & Chairman, 10% Owner Fuad El-hibri sells 15,000 Shares
Posted by: fuadelhibri on August 17, 2009
